|
Insurance & Litigation
•
|
Tools & Information
•
•
•
|
|
 Back to Reuters Health News Archives
Reuters Health News: 02-07-2005
ROME (Reuters) - Testing for mad cow disease is working in catching cases of the lethal brain-wasting disorder, the United Nations said on Monday, in the wake of several new discoveries of BSE-related cases.
NEW DELHI (Reuters) - India, home to the world's second-largest HIV population after South Africa, began its first ever human trials of a new vaccine against the deadly virus Monday, the health minister said.
SAN FRANCISCO (Reuters) - IBM on Monday will unveil software it developed in coordination with U.S. health agencies and private hospitals that makes it easier for health care workers to exchange clinical data in a medical crisis.
CHICAGO (Reuters) - Children genetically predisposed to favor sugary foods may lose their "sweet tooth" as adults, a finding that could explain why children may be at odds with their parents over food choices, researchers said on Monday.
LONDON (Reuters) - It's been described as outdated, bureaucratic, out of touch and at least one leading fertility expert has called for it to be scrapped.
PHNOM PENH (Reuters) - Bird flu has been found in chickens near the Cambodian capital, officials said Sunday, raising fears about the spread of the deadly virus in a country with little to no health system.
NEW YORK (Reuters Health) - People who have a tendency to worry or feel very stressed out may be more likely to develop Alzheimer's disease later in life, new research reports.
NEW ORLEANS (Reuters Health) - The results of a small study suggest that desmoteplase, an investigational clot-busting drug derived from vampire bat saliva, safely restores blood supply to the brain when administered up to 9 hours after a stroke occurs.
WASHINGTON (Reuters) - An advocacy group for U.S. retirees said on Friday that it won a court order barring the government from allowing companies to drop older retirees from health care coverage while retaining coverage for younger retired workers.
WASHINGTON (Reuters) - Merck & Co. Inc.'s painkiller Arcoxia offers a "marginal" advantage in gastrointestinal safety but seems "worse than" other pain drugs in terms of deaths and serious cardiovascular problems, U.S. regulatory staff said in documents released on Friday.
|
|
